SCST visits Sichuan
The Secretary for Culture, Sports and Tourism, Mr Kevin Yeung, visited the Dujiangyan Base of the China Conservation and Research Centre for the Giant Panda (CCRCGP) this morning (August 16) and attended the co-operation agreement signing ceremony on the gift of a pair of giant pandas from the Central Government to the Hong Kong Special Administrative Region (HKSAR). The agreement was jointly signed by the Party Committee Secretary and Deputy Director of the CCRCGP, Mr Lu Yongbin, and the Chairman of the Ocean Park Hong Kong, Mr Paulo Pong, on the arrival arrangements of the giant pandas, as well as on the collaboration between the two parties about the rearing and caring, breeding research and popular science education.
Mr Yeung arrived in Sichuan yesterday afternoon (August 15) and visited the Eastern Suburb Memory, a zone for cultural and creative industries in downtown Chengdu, to learn about its operation and how it has been developed into an international stage for fashion and cultural industries. Located in the Chenghua District of Chengdu and originally named Eastern Music Park, it was built on the site of the former state-run Hongguang Electronic Tube Factory, and has now been turned into a multicultural zone for a variety of cultural activities including music, arts, drama and photography. Major attractions, such as the Industrial and Cultural Square, the Old Train Display and the World of Pandas, appeal to the younger generation interested in arts and culture. The CCRCGP also hosted a dinner for the HKSAR delegation.
Mr Yeung will depart from Sichuan for Hong Kong this afternoon.
SCST visits Sichuan Source: HKSAR Government Press Releases
SCST visits Sichuan Source: HKSAR Government Press Releases
SCST visits Sichuan Source: HKSAR Government Press Releases
SCST visits Sichuan Source: HKSAR Government Press Releases
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine
The Director of Health, Dr Ronald Lam, today (September 11) witnessed in Beijing the Department of Health (DH) and the Experimental Research Center (ERC) of the China Academy of Chinese Medical Sciences (CACMS), which is a subsidiary organisation under the National Administration of Traditional Chinese Medicine (NATCM), signing a Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines (Co-operation Agreement) that covers a period of five years. The Co-operation Agreement reinforces the exchange and collaboration, jointly promote the modernisation and innovation of Chinese medicines, as well as the advancement of high-quality development of Chinese medicines.
Witnessed by Dr Ronald Lam, Director of the Department of International Co-operation (Office of Hong Kong, Macao & Taiwan Affairs) of the NATCM, Mr Wu Zhendou, and the Vice President of the CACMS, Dr Yang Hongjun, the Co-operation Agreement was signed by the Assistant Director of Health (Chinese Medicine), Dr Edmund Fong, and the Deputy Director of the ERC, Dr Yuan Yuan.
The areas of collaboration include reinforcement on research and standardization of Chinese medicines quality testing, establishment of Chinese medicines quality testing data platforms, holding expert meetings on different fields of Chinese medicines jointly. The Co-operation Agreement enhances the standard of local Chinese medicines testing technology, reinforces the exchange and collaboration on testing technology, nurtures innovative talents and further foster the internationalisation of Chinese medicines, so as to align with the national development strategies for Chinese medicines as outlined in the Development Plan for Traditional Chinese Medicine during the 14th Five-Year Plan Period.
"I would like to express my heartfelt gratitude to the NATCM and the CACMS for their continuous support to the DH, including sending Chinese medicine experts to join Hong Kong to combat the COVID-19 pandemic, arranging acupuncture experts to provide guidance and training for local Chinese medicine practitioners on smoking cessation services with the Chinese medicine and acupuncture, sending Chinese medicine experts to assist Hong Kong Special Administrative Region (HKSAR) in conducting the Chinese Medicine Practitioners Licensing Examination, and inviting HKSAR Government to participate in the 'the Fourth National Survey of Chinese Materia Medica Resources' and providing guidance in various technical aspects. We have maintained close collaboration on the inheritance and innovation of Chinese medicine and to the development of global health over the years. I earnestly look forward to deepening our co-operation and exchange in Chinese medicine through the Co-operation Agreement signed today, and continue to work together to build a healthy China, healthy Greater Bay Area, and a healthy Hong Kong!", Dr Lam said.
After the signing ceremony, Dr Lam visited the ERC and the National Resource Center for Chinese Materia Medica of the CACMS, to learn about the latest development of Chinese medicines testing and research work in the Mainland and had discussion with professional staff in the laboratories. Dr Lam stated that upon the completion and commissioning of the new building of the Government Chinese Medicines Testing Institute, there will be more opportunities for both parties to collaborate on Chinese medicines research, allowing more research results to be published in the new journal Science of Traditional Chinese Medicine.
The DH has been actively facilitating exchange and co-operation with the NATCM in the testing and reference standard research of Chinese medicines. Both parties will implement the work related to promoting the high-quality development of the traditional Chinese medicines industry as outlined in the Development Plan for Traditional Chinese Medicine during the 14th Five-Year Plan Period, including the joint construction of a quality testing platform for Chinese medicines, and accelerating the standardisation, informatisation, modernisation and internationalisation of Chinese medicines. Under this synergistic effect, it can further promote the Chinese medicines industry towards high-quality development.
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine Source: HKSAR Government Press Releases
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine Source: HKSAR Government Press Releases
